Germany's third-stage health service reform has, it is reported,launched a nationwide battle among panel doctors for patients, described in one Bonn report as a "bazaar."
Under the reform, patients can choose to remain with their current doctor or become private patients. This has reportedly unleashed a competition in which the "dear patient" is offered, in writing, a guaranteed percentage discount on treatment. However, the panel doctors' association says this offers choice to the patient but not the doctor, and that any panel doctor falsifying information in communications with patients over the conditions of reimbursement faces both legal discipline and financial penalties.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze